Connor, Clark & Lunn Investment Management (CC&L)’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $157K | Buy |
|
|||||
|
2025
Q3 | $216K | Buy |
|
|||||
|
2025
Q2 | $165K | Buy |
|
|||||
|
2025
Q1 | $127K | Hold |
|
|||||
|
2024
Q4 | $179K | Sell |
|
|||||
|
2024
Q3 | $304K | Sell |
|
|||||
|
2024
Q2 | $249K | Buy |
|
|||||
|
2024
Q1 | $276K | Buy |
|
|||||
|
2023
Q4 | $106K | Sell |
|
|||||
|
2023
Q3 | $98.4K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $9.5K | Buy |
|